Solid dispersion of meloxicam: Factorially designed dosage form for geriatric population

Open access

Solid dispersion of meloxicam: Factorially designed dosage form for geriatric population

The objective of the present work was to improve the dissolution properties of the poorly water-soluble drug meloxicam by preparing solid dispersions with hydroxyethyl cellulose (HEC), mannitol and polyethylene glycol (PEG) 4000 and to develop a dosage form for geriatric population. Differential scanning calorimetry, X-ray diffractometry, Fourier transform infrared spectroscopy and scanning electron microscopy were used to investigate the solid-state physical structure of the prepared solid dispersions. Higher in vitro dissolution of solid dispersions was recorded compared to their corresponding physical mixtures and the pure drug. PEG 4000 in 1: 9 drug to carrier ratio exhibited the highest drug release (100.2%), followed by mannitol (98.2%) and HEC (89.5%) in the same ratio. Meloxicam-PEG 4000 solid dispersion was formulated into suspension and optimization was carried out by 23 factorial design. Formulations containing higher levels of methyl cellulose and higher levels of either sodium citrate or Tween 80 exhibited the highest drug release.

British Pharamacopoeia, 4th ed., The Stationery office, London 2004, p. 1249.

B. Perissutti, F. Rubessa, M. Moneghini and D. Voinovich, Formulation design of carbamazepine fast-release tablets prepared by melt granulation technique, Int. J. Pharm.256 (2003) 53-63; DOI: 10.1016/S0378-5173(03)00062-0.

N. Seedher and S. Bhatia, Solubility Enhancement of COX-2 inhibitors using solvent systems, AAPS PharmSciTech.4 (2003) article 33.

ICH Q3C Impurities: Guidelines for residual solvents;

J. Swarbrick and C. Boylen, Encyclopedia of Pharmaceutical Technology, Vol. 2, Marcel Dekker, New York 1990, pp. 262-263.

A. Fini, J. R. Moyano, J. M. Gines, J. I. Perez-Martinez and A. M. Rabasco, Diclofenac salts. II. Solid dispersions in PEG6000 and Gelucire 50/13, Eur. J. Pharm. Biopharm.60 (2005) 99-111; DOI: 10.1016/j.ejpb.2004.11.005.

United States Pharmacopecia 24 / National Formulary 19, Asian Edition, USP Convention, Rockville (MD) 2000, p. 2303.

U. Ubaidulla, B. Senthilkumar, R. K. Khar and F. J. Ahmad, Studies on suspension of nimesulide solid dispersion: Development, characterization and in vivo evaluation, Indian J. Pharm. Sci.67 (2005) 422-426.

A. Martin, Rheology, in Physical Pharmacy (P. Bustamante and A. H. C. Chun, Eds.), 4th ed., B. I. Wavely Pvt. Ltd., New Delhi 1999, p. 424.

H. Parshad, K. Frydenvang, T. Liljefors, C. Cornett and C. Larsen, Assessment of drug salt release from solutions, suspensions and in situ suspensions using a rotating dialysis cell, Eur. J. Pharm. Sci.19 (2003) 263-272; DOI: 10.1016/S0928-0987(03)00119-2.

P. Costa and J. M. S. Lobo, Modeling and comparison of dissolution profiles, Eur. J. Pharm. Sci.13 (2001) 123-133; DOI: 10.1016/S0928-0987(01)00095-1.

D. Q. M. Craig, The mechanisms of drug release from solid dispersions in water-soluble polymers, Int. J. Pharm.231 (2002) 131-144; DOI: 10.1016-S0378-5173(01)00891-2.

N. Zajc, A. Obreza, M. Bele and S. Srcic, Physical properties and dissolution behaviour of nifedipine/mannitol solid dispersions prepared by hot melt method, Int. J. Pharm.291 (2005) 51-58; DOI: 10.1016/j.ijpharm.2004.07.042.

M. C. Gohel and L. D. Patel, Improvement of nimesulide dissolution from solid dispersions containing croscarmellose sodium and Aerosil® 200, Acta Pharm.52 (2002) 227-241.

Acta Pharmaceutica

The Journal of Croatian Pharmaceutical Society

Journal Information

IMPACT FACTOR 2017: 1.071
5-year IMPACT FACTOR: 1.623

CiteScore 2017: 1.46

SCImago Journal Rank (SJR) 2017: 0.362
Source Normalized Impact per Paper (SNIP) 2017: 0.642

Cited By


All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 217 217 36
PDF Downloads 90 90 17